We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · July 14, 2020

Cangrelor, Tirofiban, and Prasugrel Regimens in Patients With STEMI



Additional Info

Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial
Circulation 2020 Jun 27;[EPub Ahead of Print], G Gargiulo, G Esposito, M Avvedimento, et al

Further Reading